Congratulations to Delfi on this incredible milestone! Lung cancer screening could save many, many more lives with improved adoption and access. Rooting for Victor and the team live at #HLTH2023.
We are thrilled to officially introduce FirstLook Test, an accessible, accurate way to enhance #lungcancer detection through a routine blood test. Lung cancer is the #1 cancer killer in the U.S. and globally. As a #liquidbiopsy test designed for those eligible for #lungcancerscreening, FirstLook is an important tool for the #futureofhealth, capable of conveniently being initiated in #healthcare provider offices or laboratories to help determine the next best step in the lung cancer screening process. This test uses fragmentomics and advanced #machinelearning technology to compare an individual’s cell-free DNA patterns and characteristics in the blood against populations with and without cancer. FirstLook Lung uses these millions of data points to reliably identify the majority of people who will have lung cancer identified by low-dose CT scan, including early-stage disease. Beginning this fall, FirstLook will be available with select health systems in the U.S. through our Early Experience Program (EEP). Learn more about FirstLook and upcoming events like #HLTH2023 in the full release: https://lnkd.in/drfb2RJP
